Skip to main content
Top
Published in: Supportive Care in Cancer 10/2015

01-10-2015 | Original Article

Symptom burden and integrative medicine in cancer survivorship

Authors: Susanne M. Cutshall, Stephen S. Cha, Sheryl M. Ness, Daniela L. Stan, Sarah A. Christensen, Anjali Bhagra, Katharine A. Price, Carrie A. Thompson, Shahrukh K. Hashmi, Tony Y. Chon, Tracy J. McCray, Amit Sood, Brent A. Bauer, Kathryn J. Ruddy

Published in: Supportive Care in Cancer | Issue 10/2015

Login to get access

Abstract

Purpose

The purpose of the study was to learn about the level of experience with, interest in, and desire for knowledge about integrative medicine (IM) among cancer survivors.

Methods

Cancer survivors attending the 2014 National Cancer Survivors Day in Rochester, MN, were recruited to participate in a one-page survey about their ongoing health concerns and symptoms, as well as their experience with, interest in, and desire for knowledge about IM. Two-sided t test was used for univariate analyses of impact of sex, time since diagnosis, and age.

Results

Among the 260 cancer survivors, 171 persons (female, 74 %; male, 26 %) completed the survey (mean age, 64.6 years). Symptoms most commonly somewhat or more bothersome were fear of recurrence (52 %), stress (43 %), fatigue (43 %), difficulty sleeping (33 %), and weight gain (31 %). The most used IM resources were exercise (75 %), improved nutrition and diet (66 %), stress management (42 %), dietary supplementation (33 %), meditation (25 %), and massage (22 %). Older patients (age, ≥65 years) were less experienced with, interested in, and desiring of knowledge about IM techniques. Sex and time since diagnosis were not strongly predictive of most survey response categories.

Conclusions

Cancer survivors have adverse effects for years into survivorship. They use and express interest in various IM techniques to help manage symptoms. It is critical that oncology providers help survivors address ongoing health concerns. Education about and access to evidence-based IM techniques may have important roles in comprehensive cancer survivorship programs.
Literature
2.
go back to reference Pachman DR, Barton DL, Swetz KM, Loprinzi CL (2012) Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol 30(30):3687–3696CrossRefPubMed Pachman DR, Barton DL, Swetz KM, Loprinzi CL (2012) Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol 30(30):3687–3696CrossRefPubMed
3.
go back to reference Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA et al (2014) Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol 32(17):1840–1850PubMedCentralCrossRefPubMed Bower JE, Bak K, Berger A, Breitbart W, Escalante CP, Ganz PA et al (2014) Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical Oncology clinical practice guideline adaptation. J Clin Oncol 32(17):1840–1850PubMedCentralCrossRefPubMed
4.
go back to reference Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, American Society of Clinical Oncology et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32(18):1941–1967CrossRefPubMed Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, American Society of Clinical Oncology et al (2014) Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 32(18):1941–1967CrossRefPubMed
5.
go back to reference Paskett ED, Dean JA, Oliveri JM, Harrop JP (2012) Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol 30(30):3726–3733CrossRefPubMed Paskett ED, Dean JA, Oliveri JM, Harrop JP (2012) Cancer-related lymphedema risk factors, diagnosis, treatment, and impact: a review. J Clin Oncol 30(30):3726–3733CrossRefPubMed
6.
go back to reference Lenihan DJ, Cardinale DM (2012) Late cardiac effects of cancer treatment. J Clin Oncol 30(30):3657–3664, Erratum in: J Clin Oncol. 2012 Dec 20;30(36):4590CrossRefPubMed Lenihan DJ, Cardinale DM (2012) Late cardiac effects of cancer treatment. J Clin Oncol 30(30):3657–3664, Erratum in: J Clin Oncol. 2012 Dec 20;30(36):4590CrossRefPubMed
7.
go back to reference Ness S, Kokal J, Fee-Schroeder K, Novotny P, Satele D, Barton D (2013) Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum 40(1):35–42CrossRefPubMed Ness S, Kokal J, Fee-Schroeder K, Novotny P, Satele D, Barton D (2013) Concerns across the survivorship trajectory: results from a survey of cancer survivors. Oncol Nurs Forum 40(1):35–42CrossRefPubMed
8.
go back to reference Lynch BM, Dunstan DW, Vallance JK, Owen N (2013) Don’t take cancer sitting down: a new survivorship research agenda. Cancer 119(11):1928–1935CrossRefPubMed Lynch BM, Dunstan DW, Vallance JK, Owen N (2013) Don’t take cancer sitting down: a new survivorship research agenda. Cancer 119(11):1928–1935CrossRefPubMed
9.
go back to reference Zheng Y, Luo J, Bao P, Cai H, Hong Z, Ding D et al (2014) Long-term cognitive function change among breast cancer survivors. Breast Cancer Res Treat 146(3):599–609CrossRefPubMed Zheng Y, Luo J, Bao P, Cai H, Hong Z, Ding D et al (2014) Long-term cognitive function change among breast cancer survivors. Breast Cancer Res Treat 146(3):599–609CrossRefPubMed
10.
go back to reference Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL et al (2014) Survivorship: cognitive function, version 1.2014. J Natl Compr Cancer Netw 12(7):976–986 Denlinger CS, Ligibel JA, Are M, Baker KS, Demark-Wahnefried W, Friedman DL et al (2014) Survivorship: cognitive function, version 1.2014. J Natl Compr Cancer Netw 12(7):976–986
11.
go back to reference Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF et al (2007) Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 16(8):772–777PubMedCentralCrossRefPubMed Ferguson RJ, Ahles TA, Saykin AJ, McDonald BC, Furstenberg CT, Cole BF et al (2007) Cognitive-behavioral management of chemotherapy-related cognitive change. Psychooncology 16(8):772–777PubMedCentralCrossRefPubMed
12.
go back to reference Raggio GA, Butryn ML, Arigo D, Mikorski R, Palmer SC (2014) Prevalence and correlates of sexual morbidity in long-term breast cancer survivors. Psychol Health 29(6):632–650CrossRefPubMed Raggio GA, Butryn ML, Arigo D, Mikorski R, Palmer SC (2014) Prevalence and correlates of sexual morbidity in long-term breast cancer survivors. Psychol Health 29(6):632–650CrossRefPubMed
13.
go back to reference Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16(2):501–514PubMed Ganz PA, Rowland JH, Desmond K, Meyerowitz BE, Wyatt GE (1998) Life after breast cancer: understanding women’s health-related quality of life and sexual functioning. J Clin Oncol 16(2):501–514PubMed
14.
go back to reference Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ (2011) The supportive care needs of men with advanced prostate cancer. Oncol Nurs Forum 38(2):189–198CrossRefPubMed Carter N, Bryant-Lukosius D, DiCenso A, Blythe J, Neville AJ (2011) The supportive care needs of men with advanced prostate cancer. Oncol Nurs Forum 38(2):189–198CrossRefPubMed
15.
go back to reference Lebel S, Maheu C, Lefebvre M, Secord S, Courbasson C, Singh M et al (2014) Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv 8(3):485–496CrossRefPubMed Lebel S, Maheu C, Lefebvre M, Secord S, Courbasson C, Singh M et al (2014) Addressing fear of cancer recurrence among women with cancer: a feasibility and preliminary outcome study. J Cancer Surviv 8(3):485–496CrossRefPubMed
16.
go back to reference Eisenberg SA, Kurita K, Taylor-Ford M, Agus DB, Gross ME, Meyerowitz BE (2015) Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors. Psychooncology 24(2):228–235CrossRefPubMed Eisenberg SA, Kurita K, Taylor-Ford M, Agus DB, Gross ME, Meyerowitz BE (2015) Intolerance of uncertainty, cognitive complaints, and cancer-related distress in prostate cancer survivors. Psychooncology 24(2):228–235CrossRefPubMed
17.
go back to reference McCarthy M (2014) Cancer survivors face substantial financial burdens, US report says. BMJ 348:g4017CrossRefPubMed McCarthy M (2014) Cancer survivors face substantial financial burdens, US report says. BMJ 348:g4017CrossRefPubMed
18.
go back to reference Feng Y, Wang XY, Li SD, Zhang Y, Wang HM, Li M et al (2011) Clinical research of acupuncture on malignant tumor patients for improving depression and sleep quality. J Tradit Chin Med 31(3):199–202CrossRefPubMed Feng Y, Wang XY, Li SD, Zhang Y, Wang HM, Li M et al (2011) Clinical research of acupuncture on malignant tumor patients for improving depression and sleep quality. J Tradit Chin Med 31(3):199–202CrossRefPubMed
19.
go back to reference Mehling WE, Jacobs B, Acree M, Wilson L, Bostrom A, West J et al (2007) Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial. J Pain Symptom Manag 33(3):258–266CrossRef Mehling WE, Jacobs B, Acree M, Wilson L, Bostrom A, West J et al (2007) Symptom management with massage and acupuncture in postoperative cancer patients: a randomized controlled trial. J Pain Symptom Manag 33(3):258–266CrossRef
20.
go back to reference Molassiotis A, Sylt P, Diggins H (2007) The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med 15(4):228–237CrossRefPubMed Molassiotis A, Sylt P, Diggins H (2007) The management of cancer-related fatigue after chemotherapy with acupuncture and acupressure: a randomised controlled trial. Complement Ther Med 15(4):228–237CrossRefPubMed
21.
go back to reference Walker EM, Rodriguez AI, Kohn B, Ball RM, Pegg J, Pocock JR et al (2010) Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 28(4):634–640CrossRefPubMed Walker EM, Rodriguez AI, Kohn B, Ball RM, Pegg J, Pocock JR et al (2010) Acupuncture versus venlafaxine for the management of vasomotor symptoms in patients with hormone receptor-positive breast cancer: a randomized controlled trial. J Clin Oncol 28(4):634–640CrossRefPubMed
22.
go back to reference Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder DW, Filshie J et al (2012) Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol 30(36):4470–4476CrossRefPubMed Molassiotis A, Bardy J, Finnegan-John J, Mackereth P, Ryder DW, Filshie J et al (2012) Acupuncture for cancer-related fatigue in patients with breast cancer: a pragmatic randomized controlled trial. J Clin Oncol 30(36):4470–4476CrossRefPubMed
23.
go back to reference Balk J, Day R, Rosenzweig M, Beriwal S (2009) Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigue. J Soc Integr Oncol 7(1):4–11PubMed Balk J, Day R, Rosenzweig M, Beriwal S (2009) Pilot, randomized, modified, double-blind, placebo-controlled trial of acupuncture for cancer-related fatigue. J Soc Integr Oncol 7(1):4–11PubMed
24.
go back to reference Hervik J, Mjaland O (2010) Quality of life of breast cancer patients medicated with anti-estrogens, 2 years after acupuncture treatment: a qualitative study. Int J Womens Health 2:319–325PubMedCentralCrossRefPubMed Hervik J, Mjaland O (2010) Quality of life of breast cancer patients medicated with anti-estrogens, 2 years after acupuncture treatment: a qualitative study. Int J Womens Health 2:319–325PubMedCentralCrossRefPubMed
25.
go back to reference Loprinzi CE, Prasad K, Schroeder DR, Sood A (2011) Stress Management and Resilience Training (SMART) program to decrease stress and enhance resilience among breast cancer survivors: a pilot randomized clinical trial. Clin Breast Cancer 11(6):364–368CrossRefPubMed Loprinzi CE, Prasad K, Schroeder DR, Sood A (2011) Stress Management and Resilience Training (SMART) program to decrease stress and enhance resilience among breast cancer survivors: a pilot randomized clinical trial. Clin Breast Cancer 11(6):364–368CrossRefPubMed
26.
go back to reference Lengacher CA, Reich RR, Paterson CL, Jim HS, Ramesar S, Alinat CB, et al (2014) The effects of mindfulness-based stress reduction on objective and subjective sleep parameters in women with breast cancer: a randomized controlled trial. Psychooncology. doi:10.1002/pon.3603 Lengacher CA, Reich RR, Paterson CL, Jim HS, Ramesar S, Alinat CB, et al (2014) The effects of mindfulness-based stress reduction on objective and subjective sleep parameters in women with breast cancer: a randomized controlled trial. Psychooncology. doi:10.​1002/​pon.​3603
27.
go back to reference Johns SA, Brown LF, Beck-Coon K, Monahan PO, Tong Y, Kroenke K (2014) Randomized controlled pilot study of mindfulness-based stress reduction for persistently fatigued cancer survivors. Psychooncology. doi:10.1002/pon.3648 Johns SA, Brown LF, Beck-Coon K, Monahan PO, Tong Y, Kroenke K (2014) Randomized controlled pilot study of mindfulness-based stress reduction for persistently fatigued cancer survivors. Psychooncology. doi:10.​1002/​pon.​3648
28.
go back to reference Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS (2014) Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol 32(5):449–457CrossRefPubMed Garland SN, Carlson LE, Stephens AJ, Antle MC, Samuels C, Campbell TS (2014) Mindfulness-based stress reduction compared with cognitive behavioral therapy for the treatment of insomnia comorbid with cancer: a randomized, partially blinded, noninferiority trial. J Clin Oncol 32(5):449–457CrossRefPubMed
Metadata
Title
Symptom burden and integrative medicine in cancer survivorship
Authors
Susanne M. Cutshall
Stephen S. Cha
Sheryl M. Ness
Daniela L. Stan
Sarah A. Christensen
Anjali Bhagra
Katharine A. Price
Carrie A. Thompson
Shahrukh K. Hashmi
Tony Y. Chon
Tracy J. McCray
Amit Sood
Brent A. Bauer
Kathryn J. Ruddy
Publication date
01-10-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 10/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2666-0

Other articles of this Issue 10/2015

Supportive Care in Cancer 10/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine